您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Osteoporosis Drugs Market Report

健康网讯：

Market Research Report On Osteoporosis Drugs
 
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,960 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Foreword
Categories of Osteoporosis Drugs
1. Market scale and growth trend of Osteoporosis Drugs
  1.1 Sales value and growth trend of drugs for regulating bone
 metabolism in the past few years
  1.2 Market scale of bone mineralization drugs in the past few years
    1.2.1 Market share of different breeds of calcium preparations 
    1.2.2 Market share of vitD and it's active metabolites
  1.3 Growth trend of Representative Osteoporosis Drugs in the past few
 years
    1.3.1 Calcitonin class
    1.3.2 Phosphonate class
    1.3.3 Hormone class
2.Sales ananlysis about top breeds or brands in the past few years
  2.1 Sales rank of breeds
  2.2 Sales rank of key brands
  2.3 Sales shares of key enterprises on key breeds
    Calcitonin
    Alendronate Sodium
    Elcitonin
    Disodium Clodronate
    Etidronate Disodium
    Raloxifene
    Ipriflavone
  2.4 Indicative retail prices of key breeds
3 Sales statistics of key brands in key cities
    "Miacalcic"
    "FuShanMei"
    "YiGaiNing"
    "GuBang"
    "GuLing"
    "BangRuiDe"
    "YiWeiTe"
    "Bangtelin"
4 Sales share of different brands in key cities
  Shanghai
  Beijing
  Guangzhou
5 Research and development in China
  5.1 List of Domestic marketd products and import procucts
  5.2 Status of application and approval